The inhibition of AChE is a potential therapeutic target for the treatment of AD but targeting ChEs alone is not sufficient and thus exploration of multi-target molecules focusing also on other proposed molecular mechanisms of AD such as β-amyloid cascade or oxidative stress is required. This evidence concerns the gene PPIB and Alzheimer disease.